Search clinical trials for: 23-valent pneumococcal vaccine

Total 10092 results

VA Sierra Nevada Health Care System
Merck Sharp & Dohme LLC

Not yet recruiting

Evaluation of PCV15 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans

Immunosuppression | Pneumococcal Vaccines
CanSino Biologics Inc.

Recruiting

A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)

Pertussis | Tetanus | Diphtheria

China
Aimei Vacin BioPharm (Zhejiang) Co., Ltd.

Recruiting

A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People

Pneumococcal Disease

China
Novartis Pharmaceuticals

Recruiting

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS (ALITHIOS)

Relapsing Multiple Sclerosis

United States, Australia, Austria, Belgium, Bulgaria, Canada, Germany, Hungary, Poland, Portugal, Russian Federation, Slovakia, Spain, Denmark, France, Japan, Israel, Taiwan, Turkey, Czechia, Argentina, Estonia, United Kingdom, India, C... and more
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)

Pneumococcal Infection

United States, Puerto Rico
Ab&b Biotechnology Co., Ltd.JS
Henan Center for Disease Control and Prevention

Completed

Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above

Pneumonia

China
Region Skane

Completed

Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease (IPS-BOOSTER)

Rheumatoid Arthritis | Systemic Vasculitis | Spondyloarthritis | Systemic Lupus | Sjögren Syndrome
China National Biotec Group Company Limited
Peking University; Hunan Provincial Center for Disease Control and Prevention; Guizhou Center for Disease Control and Prevention and other collaborators

Completed

Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

Pneumonia, Pneumococcal | Influenza, Human

China
Canadian Immunization Research Network

Completed

Vaccinating Children After Chemotherapy

Acute Lymphoblastic Leukemia

Canada
Sinovac Research and Development Co., Ltd.

Completed

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine

COVID-19

China
China National Biotec Group Company Limited
Shanghai Municipal Center for Disease Control and Prevention

Completed

A Clinical Trial to Evaluate the Safety and Immunogenicity of PPV23 Vaccine Revaccinated in 60-70 Years Old

Vaccination

China
China National Biotec Group Company Limited
Sichuan Center for Disease Control and Prevention

Completed

A Clinical Trial to Evaluate the Immunogenicity and Safety of PPV23 Vaccine Revaccinations in the Elderly

Vaccination

China
Pfizer

Completed

Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults

Pneumococcal Infections

United States
Institut National de la Santé Et de la Recherche...

Completed

Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response (PNEUMOVACB)

Pneumococcal Diseases

France
VA Office of Research and Development

Terminated

Pneumococcal Conjugate Vaccine in Aging Renal Transplant

Aging | Renal Transplantation

United States
Sungkyunkwan University
Government-wide R&D Fund project for infectious disease research

Unknown

Post-marketing Safety Evaluation of Pneumococcal Vaccines Among Children and Elderly Adults.

Pneumococcal Vaccine Adverse Reaction

Korea, Republic of
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Completed

Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above

Pneumonia, Pneumococcal

China
PATH

Completed

Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants

Pneumococcal Disease

Gambia
Kameda Medical Center
Merck Sharp & Dohme LLC; PPD; Osaka University

Completed

The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine

Influenza | Pneumococcal Pneumonia

Japan
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Systems Biology of PNEUMOVAX®23 and PREVNAR 13®

Pneumococcal Infection

United States
Genentech, Inc.

Completed

A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate (SIERRA)

Rheumatoid Arthritis

United States
Biogen

Completed

Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.

Relapsing Forms of Multiple Sclerosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine

Pneumococcal Infection

United States
University of Siena
Catholic University of the Sacred Heart

Withdrawn

Antibodies and Memory Cells Role After Different Pneumococcal Vaccines in HIV Adults

Pneumococcal Infections | HIV

Italy
University of Florida

Completed

The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23 (StatVax)

Healthy Controls

United States
University of Toledo Health Science Campus
National Institute on Aging (NIA)

Completed

Pneumonia Vaccine in Aging HIV Positive Individuals

Pneumococcal Infection

United States
University of Minnesota
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease (PNEUMO)

Pulmonary Disease, Chronic Obstructive

United States
Pfizer

Completed

Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine

HIV Infections | Pneumococcal Infections

South Africa, Romania
Kyunghee University Medical Center
Asan Medical Center; Seoul National University Hospital; Korea University; Chung-Ang... and other collaborators

Completed

Efficacy Study of Pneumococcal Vaccination in Crohn's Disease

Crohn's Disease

Korea, Republic of
University of Sao Paulo

Completed

23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy

Juvenile Idiopathic Arthritis

Brazil
Naval Health Research Center
U.S. Army Medical Research and Development Command

Completed

Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits

Pneumonia | Acute Respiratory Disease

United States
Jiangsu Province Centers for Disease Control and...
Shanghai Institute Of Biological Products; Chengdu Institute of Biological...

Completed

Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults

Influenza | Pneumococcal Infection

China
Pfizer

Completed

A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older

Pneumococcal Vaccines | Pneumococcal Conjugate Vaccine

Japan
Genentech, Inc.

Completed

A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)

Rheumatoid Arthritis

United States
Centers for Disease Control and Prevention
Emory University

Completed

Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine

Pneumococcal Infections

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPS

Pneumococcal Vaccines

United States
Cedars-Sinai Medical Center

Completed

Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease

Crohn Disease | Ulcerative Colitis | Inflammatory Bowel Disease

United States
French National Agency for Research on AIDS and...
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.

HIV Infections
University of Melbourne
National Health and Medical Research Council, Australia; Menzies School of...

Unknown

PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease

Pneumococcal Infections | Tympanic Membrane Perforation | Acute Otitis Media | Middle Ear Effusion

Australia
Sanofi Pasteur, a Sanofi Company

Recruiting

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (CORAL)

RSV Immunization

United States, Puerto Rico
Germans Trias i Pujol Hospital

Not yet recruiting

Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants (LYMPHODEP)

Depression | Inflammation | Immunity | Antidepressants

Spain
University of Ottawa

Not yet recruiting

Education to Improve Pneumococcal Vaccine Uptake Among Older Adults (PROPEL)

Pneumococcal Vaccine Uptake | Vaccination Willingness | Pneumococcal Vaccine Knowledge | Pneumococcal Vaccine Attitude

Canada
GlaxoSmithKline
Kwame Nkrumah University of Science and Technology; European & Developing Countries... and other collaborators

Recruiting

A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants

Salmonella Infections

Ghana
Leiden University Medical Center

Recruiting

Fine Needle aSpiration of Lymph nodEs to Study vAccine-induced Immunity (SEA)

Vaccine-Preventable Diseases

Netherlands
Sinovac Research and Development Co., Ltd.

Recruiting

A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Pneumococcal Infectious Disease

China
Pfizer

Recruiting

A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults

Pneumococcal Disease

United States
M.D. Anderson Cancer Center

Recruiting

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

Esophageal Cancer | Chemoradiation | Lymphopenia | Pneumococcal Vaccine

United States
Merck Sharp & Dohme LLC

Recruiting

A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013) (STRIDE-13)

Pneumococcal Infection

France, United States, Japan, Canada, Turkey, Finland, Spain, Poland, Sweden, Chile, Colombia, Israel, Thailand
Geisinger Clinic

Recruiting

Pneumonia Vaccine Education Intervention Study (PVI)

Pneumonia, Pneumococcal | Vaccine

United States
State University of New York at Buffalo
National Institute on Aging (NIA)

Recruiting

The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses

Aging

United States

Search clinical trials for: 23-valent pneumococcal vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations